<DOC>
	<DOCNO>NCT02778919</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety , dose-response relationship KLH-2109 compare placebo Japanese patient endometriosis .</brief_summary>
	<brief_title>Late Phase II Clinical Study KLH-2109 Patients With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Female patient endometriosis Patients clinically significant hepatic , renal , cardiovascular dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Endometriosis</keyword>
</DOC>